Triple drug combination shows promise in Covid-19 treatment
Early data from a small trial conducted by the University of Hong Kong has demonstrated...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Cocrystal Pharma to study hepatitis C drug in Hong Kong
US-based biotechnology firm Cocrystal Pharma has signed a clinical trial agreement with Humanity & Health...
M&As this week: Zymergen, Celgene Corp, China Biology Services Group Limited
Molecular technology firm Zymergen Inc has acquired Radiant Genomics Inc, a functional metagenomics research company.
Deals this week: AmpliPhi Biosciences, Argos Therapeutics, Juvenescence Limited
AmpliPhi Biosciences Corp plans to issue shares of its common stock in a public offering.